| Janssen-Cilag AG - Imbruvica 140 mg, Filmtabletten | | 67109 | | 01 | | Imbruvica 140 mg | | Filmtabletten | | L01EL01 | | Ibrutinib | | 18.04.2019 | | |
| | Composition | | ibrutinibum 140 mg, lactosum monohydricum 28 mg, carmellosum natricum conexum, natrii laurilsulfas, povidonum K 25, cellulosum microcristallinum, silica colloidalis anhydrica, magnesii stearas, Überzug: poly(alcohol vinylicus), macrogolum, talcum, E 171, E 172, pro compresso obducto corresp. natrium 1.14 mg. | | Packungsbestandteile | | Coated tablets | | | | | Active Agent | Dose |
|---|
| Ibrutinibum | 140 mg |
| | BAG: Active Agent | Dose |
|---|
| Ibrutinibum | 140 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| Carmellosum Natricum Conexum | | | | Cellulosum Microcristallinum | | | | E 171 | | color. | | E 172 | | color. | | Lactose Monohydrate | 28 mg | | | Macrogol | | | | Magnesii Stearas | | | | Natrii Laurilsulfas | | | | Poly(Alcohol Vinylicus) | | Überzug | | Povidonum K | 25 | | | Pro Compresso Obducto | | | | Silica Colloidalis Anhydrica | | | | Talcum | | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 005 | 28 | 1372.51 | 1509.10 | A | SL | No |
|
|
